A randomized, double-blind multicenter 2-stage phase III study of bevacizumab in combination with cisplatin and gemcitabine versus placebo, cisplatin and gemcitabine in patients with advanced or recurrent non-squamous non-small cell lung cancer, who have not received prior chemotherapy
Grant Data
Project Title
A randomized, double-blind multicenter 2-stage phase III study of bevacizumab in combination with cisplatin and gemcitabine versus placebo, cisplatin and gemcitabine in patients with advanced or recurrent non-squamous non-small cell lung cancer, who have not received prior chemotherapy
Principal Investigator
Dr Ho, James Chung Man
(Principal Investigator)
Duration
27
Start Date
2005-04-14
Amount
343379
Conference Title
A randomized, double-blind multicenter 2-stage phase III study of bevacizumab in combination with cisplatin and gemcitabine versus placebo, cisplatin and gemcitabine in patients with advanced or recurrent non-squamous non-small cell lung cancer, who have not received prior chemotherapy
Presentation Title
Keywords
AVAiL
Discipline
Cancer
HKU Project Code
N/A
Grant Type
F Hoffmann-La Roche and Co. Ltd. - General Award
Funding Year
2004
Status
Completed